DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Botox Market

Global Botox Market Opportunities and Forecast 2020-2027

  • DLR2720
  • 13 August, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Botox Market, By Type (Botulinum Toxin A, and Botulinum Toxin B), By Application (Therapeutic, and Aesthetic), By End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others) and opportunities and forecast 2020-2027

Botox Market Overview

The global Botox Market is expected to grow at a moderate rate during the forecast period. Growing awareness and demand for botox treatment is boosting the growth of the global healthcare biometric market. An incidences of skin conditions which require botox treatment, to expand the growth of the market.

Moreover, surge in demand for improvement in aesthetics is the important factor expected to boost the growth of the Botox Market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.

On the other hand, unavailability of skilled professionals for botox treatment along with the challenges associated with the usage of botox chemicals is likely to hamper the global Botox Market during the forecast period.

Covid-19 Impact on Botox Market:

In addition, the current Botox Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Botox Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which Inc.ludes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The Inc.reasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Botox Market Segment Overview

According to Type, the market is segmented into Botulinum Toxin A, and Botulinum Toxin B. Among these Botulinum Toxin A holds the largest share of the market mainly because of the growth in demand for botulinum toxin A and surge in acceptance of patients for the treatment due to minimal side effects.

Based on application, the market is divided into therapeutic, and aesthetic. Furthermore, therapeutic segment are expected to grow at the highest rate in the coming years. Increase in spending for therapeutics of skin related conditions and rise in investment for bringing up products which are cost-effective against the skin conditions are expected to boost the demand for Botox globally.

Market Analysis, Insights and Forecast – By Type

·       Botulinum Toxin A
·       Botulinum Toxin B

Market Analysis, Insights and Forecast – By Application

·       Therapeutic
·       Aesthetic

Market Analysis, Insights, and Forecast – By End-user

·       Specialty & Dermatology Clinics
·       Hospitals & Clinics
·       Others

Botox Market Regional Overview

Region-wise, North America dominated the global Botox Market and is expected to continue its dominance during the forecast period. Factors such as the rising number skin conditions around the world, and high health care expenditure & spending on improvement of aesthetics propels the growth of the market in North America. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about methods to improve aesthetics, a surge in investment in pharmaceuticals and biotechnology for improvement in botox products, and growing adoption of botox treatment are expected to escalate the growth of the Botox Market in the Asia Pacific region.

Botox Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Botox Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Botox are highlighted below.

·       In July 2020, Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX for the treatment of spasticity in pediatric patients 2 years of age and older, including those with lower limb spasticity caused by cerebral palsy.

Botox Market, Key Players

·       Allergan
·       Merz Pharma
·       Medytox
·       Galderma
·       Lanzhou Institute of Biological Products Co.,Ltd
·       Hugel,Inc.
·       Revanance Therapeutics,Inc.
·       US WorldMeds,LLC
·       Ipsen group
·       Eisai Co., Ltd
·       Evolus, Inc.
·       AbbVie
·       Pfizer Inc.

Botox Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Botox Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. Botulinum Toxin A
        • 5.2.2. Botulinum Toxin B
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Therapeutic
        • 5.3.2. Aesthetic
      • 5.4. Market Analysis, Insights and Forecast – By End-user
        • 5.4.1. Specialty & Dermatology Clinics
        • 5.4.2. Hospitals & Clinics
        • 5.4.3. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East, and Africa

      6. North America Botox Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. Botulinum Toxin A
        • 6.2.2. Botulinum Toxin B
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Therapeutic
        • 6.3.2. Aesthetic
      • 6.4. Market Analysis, Insights and Forecast – By End-user
        • 6.4.1. Specialty & Dermatology Clinics
        • 6.4.2. Hospitals & Clinics
        • 6.4.3. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Botox Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. Botulinum Toxin A
        • 7.2.2. Botulinum Toxin B
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Therapeutic
        • 7.3.2. Aesthetic
      • 7.4. Market Analysis, Insights and Forecast – By End-user
        • 7.4.1. Specialty & Dermatology Clinics
        • 7.4.2. Hospitals & Clinics
        • 7.4.3. Others
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Botox Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. Botulinum Toxin A
        • 8.2.2. Botulinum Toxin B
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Therapeutic
        • 8.3.2. Aesthetic
      • 8.4. Market Analysis, Insights and Forecast – By End-user
        • 8.4.1. Specialty & Dermatology Clinics
        • 8.4.2. Hospitals & Clinics
        • 8.4.3. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East, and Africa Botox Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Type
        • 9.2.1. Botulinum Toxin A
        • 9.2.2. Botulinum Toxin B
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Therapeutic
        • 9.3.2. Aesthetic
      • 9.4. Market Analysis, Insights and Forecast – By End-user
        • 9.4.1. Specialty & Dermatology Clinics
        • 9.4.2. Hospitals & Clinics
        • 9.4.3. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Allergan
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Merz Pharma
      • 10.6. Medytox
      • 10.7. Galderma
      • 10.8. Lanzhou Institute of Biological Products Co.,Ltd
      • 10.9. Hugel,Inc.
      • 10.10. Revanance Therapeutics,Inc.
      • 10.11. US WorldMeds,LLC
      • 10.12. Ipsen group
      • 10.13. Eisai Co., Ltd
      • 10.14. Evolus, Inc.
      • 10.15. AbbVie

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934